World Journal of Clinical Oncology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Depar FN, Chaudhary AJ, Hameed J, Abbasi FS, Uzma B, Ali A, Akhtar N, Khan R, Siddiqi A, Riaz S. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World J Clin Oncol 2026; 17(2): 116251 [PMID: 41810343 DOI: 10.5306/wjco.v17.i2.116251]
URL:	https://www.wjgnet.com/2218-4333/full/v17/i2/116251.htm

Number	Citing Articles
1	Ilya Klabukov, Denis Baranovskii, Daria Eygel, Elena Yatsenko. Letter to the Editor: Cancer stem cell and oncomatrix biomarkers predict chemotherapy response and survival in triple-negative breast cancer. World Journal of Clinical Oncology 2026; 17(7): 120955 doi: 10.5306/wjco.120955 Abstract(26) \| Core Tip(28) \| Full Article(HTML)(120) \| Full Article (PDF)-361K(16) \| Full Article with Cover (PDF)-701K(6) \| Full Article (XML)-38K(6) \| Audio-130K(0) \| Peer-Review Report-186K(12) \| Answering Reviewers-150K(16) \| Times Cited (0) \| Total Visits (148) \| Open
2	Sunil V Jagtap, Shubham S Jagtap. Prognostic significance of stem cell markers: In triple-negative breast cancers. World Journal of Clinical Oncology 2026; 17(7): 119673 doi: 10.5306/wjco.v17.i7.119673 Abstract(36) \| Core Tip(37) \| Full Article(HTML)(261) \| Full Article (PDF)-389K(88) \| Full Article with Cover (PDF)-726K(34) \| Full Article (XML)-70K(26) \| Audio-197631K(6) \| Peer-Review Report-242K(23) \| Answering Reviewers-349K(20) \| Times Cited (0) \| Total Visits (444) \| Open
3	Tian Fang, Mengxing Zhang, Chang Ma, Min Dong, Xinhao Song, Junqi Wang, Runan Zuo, Jinwei You, Yingfeng Zhao, Shanxiang Jiang, Dawei Guo. Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours. Veterinary and Comparative Oncology 2026; 24(3) doi: 10.1111/vco.70085